Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Cluster of differentiation 20 (CD20)-positive, follicular Non-Hodgkin's lymphoma grade 1, 2, 3a. A tumor biopsy must have been performed within 6 months before study entry with material available for central review
No prior treatment
Eastern Cooperative Oncology Group (ECOG) performance status 0-2
You may not be if
Grade 3b follicular lymphoma
Transformation to high-grade lymphoma secondary to follicular lymphoma
Types of Non-Hodgkin's lymphoma other than follicular lymphoma
Presence or history of central nervous system (CNS) disease
Corticoid therapy during the last 4 weeks, except prednisone treatment less than (\<) 20 milligrams per day (mg per day)
Known active bacterial, viral, fungal, or mycobacterial, or any major episode of infections requiring hospitalization or treatment with IV antibiotics within 4 weeks of start of study medication, or oral antibiotics within 2 weeks prior to start of study medication
